Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.210
-0.060 (-2.64%)
Feb 21, 2025, 4:00 PM EST - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $743.81 million as of February 21, 2025. Its market cap has increased by 109.71% in one year.
Market Cap
743.81M
Enterprise Value
205.87M
1-Year Change
109.71%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $743.81M, an increase of 326.31%. That is a compound annual growth rate of 38.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 743.81M | -16.92% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |